Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

174.56
Delayed Data
As of Feb 24
 +0.55 / +0.32%
Today’s Change
133.64
Today|||52-Week Range
176.85
+19.39%
Year-to-Date
Ligand (LGND) Q4 Earnings Down Y/Y, Revenues Miss Estimates
Feb 24 / Zacks.com - Paid Partner Content
Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease
Feb 22 / MotleyFool.com - Paid Partner Content
Why 3D Printing and Biotech Will Be Good Bets in 2017
Feb 23 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising
Feb 22 / Zacks.com - Paid Partner Content
Better Cloud Growth Stock: Twilio Inc. vs. Veeva Systems
Feb 23 / MotleyFool.com - Paid Partner Content
Top Research Reports for Amgen, Bank of America, and Proctor & Gamble
Feb 21 / Zacks.com - Paid Partner Content
Who Could Buy Bristol-Myers Squibb?
Feb 22 / MotleyFool.com - Paid Partner Content
Study Reveals PCSK9 Drugs Can Save Heart Disease Patients
Feb 21 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Amgen, Procter & Gamble, Bank of America, Netflix ...
Feb 22 / Zacks.com - Paid Partner Content
Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
Feb 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close174.01
Today’s open173.29
Day’s range172.48 - 174.72
Volume2,677,307
Average volume (3 months)3,977,868
Market cap$128.6B
Dividend yield2.64%
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+6.49%
Earnings growth (next 5 years)+7.78%
Revenue growth (last year)+6.31%
P/E ratio17.5
Price/Sales4.86
Price/Book4.31

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.57+0.82%
BIIBBiogen+0.38+0.13%
ILMNIllumina Inc-1.01-0.63%
BIVVBioverativ Inc+1.40+2.82%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateApril 25, 2017
EPS forecast (this quarter)$2.99
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs